Skip to content

Opening book details…

About this Medicine article

A randomized phase II trial of amonafide or trimetrexate in patients with advanced non-small cell lung cancer. A trial of the north central cancer treatment group by Dean H. Gesme Jr.; James R. Jett; Dennis D. Schreffler; John Q. Su; James A. Mailliard; John F. Foley; James E. Krook; Andrew W. Maksymiuk; Alan K. Hatfield; Larry P. Ebbert; Delano M. Pfeifle; Roscoe F. Morton; Loren K. Tschetter; Paul I. Schaefer is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Dean H. Gesme Jr.; James R. Jett; Dennis D. Schreffler; John Q. Su; James A. Mailliard; John F. Foley; James E. Krook; Andrew W. Maksymiuk; Alan K. Hatfield; Larry P. Ebbert; Delano M. Pfeifle; Roscoe F. Morton; Loren K. Tschetter; Paul I. Schaefer
Publisher
John Wiley and Sons; Wiley (John Wiley & Sons); John Wiley & Sons Inc.; Wiley (ISSN 0008-543X)
Published
1993
Language
EN
Field
Medicine (Health Sciences)

More by Dean H. Gesme Jr.; James R. Jett; Dennis D. Schreffler; John Q. Su; James A. Mailliard; John F. Foley; James E. Krook; Andrew W. Maksymiuk; Alan K. Hatfield; Larry P. Ebbert; Delano M. Pfeifle; Roscoe F. Morton; Loren K. Tschetter; Paul I. Schaefer

Browse all works by Dean H. Gesme Jr.; James R. Jett; Dennis D. Schreffler; John Q. Su; James A. Mailliard; John F. Foley; James E. Krook; Andrew W. Maksymiuk; Alan K. Hatfield; Larry P. Ebbert; Delano M. Pfeifle; Roscoe F. Morton; Loren K. Tschetter; Paul I. Schaefer